Braun Stacey Associates Inc Astrazeneca PLC Transaction History

Braun Stacey Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$66.81 - $80.83 $3.17 Million - $3.84 Million	-47,503 Reduced 70.03%	20,325 $1.59 Million
Q1 2024 Apr 30, 2024	SELL	$61.03 - $69.57 $2.67 Million - $3.04 Million	-43,676 Reduced 39.17%	67,828 $4.6 Million
Q4 2023 Jan 23, 2024	SELL	$61.89 - $69.28 $1.77 Million - $1.98 Million	-28,590 Reduced 20.41%	111,504 $7.51 Million
Q3 2023 Nov 21, 2023	SELL	$64.85 - $71.7 $2.29 Million - $2.53 Million	-35,305 Reduced 20.13%	140,094 $9.49 Million
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $10.5 Million - $11.4 Million	-150,879 Reduced 46.24%	175,399 $12.6 Million
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $11.6 Million - $13.2 Million	184,006 Added 129.33%	326,278 $22.6 Million
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $1.34 Million - $1.75 Million	-24,786 Reduced 14.84%	142,272 $9.65 Million
Q3 2022 Nov 08, 2022	SELL	$53.02 - $135.75 $2.01 Million - $5.15 Million	-37,955 Reduced 18.51%	167,058 $9.16 Million
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $12.1 Million - $14.6 Million	205,013 New	205,013 $13.5 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.